Medication info
Coscayex Tablets 5/50 Milligrams

Coscayex Tablets 5/50 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
SK Chemical Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
Bottle packaging - 30 tablets/bottle
Approval status
Active

MFDS item code 201802436 · Approved 2018.06.12 · Insurance code 644704630

Summary

Main use
Treatment of essential hypertension when uncontrolled with monotherapy and of stage 2 essential hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with either individual component, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. This medicine is usually administered at 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For patients aged 75 years and older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, this medicine is not recommended for use as initial therapy.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
SK Chemical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension when uncontrolled with monotherapy and of stage 2 essential hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medicine is used in patients with essential hypertension who find it difficult to control blood pressure with either amlodipine or losartan monotherapy. It is also effective when starting combination therapy to achieve target blood pressure in patients with stage 2 hypertension. This medication helps in the treatment of hypertension for stable blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with either individual component, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. This medicine is usually administered at 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For patients aged 75 years and older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, this medicine is not recommended for use as initial therapy.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus, especially in the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. If pregnant women take this medicine, there can be severe problems for the fetus such as hypotension, impaired kidney function, and cranial formation anomalies, so caution is necessary. This medication can cause hypotension when initially administered to patients with decreased effective blood volume, so the patient's condition should be checked carefully before administration. This medication should not be used in patients with hypersensitivity to its active ingredients, pregnant or breastfeeding women, patients with severe liver dysfunction, severe aortic stenosis patients, and patients in shock. In patients with decreased blood volume or impaired kidney function, patients required to have strict sodium restrictions, and patients with hyperkalemia, careful administration is necessary. Side effects such as dizziness, headache, drowsiness, abdominal discomfort, skin rash, palpitations, and orthostatic hypotension can occur, and if abnormal symptoms appear, it should be reported. Due to its blood pressure-lowering effect, caution is needed when driving or operating dangerous machinery, and the hypotensive effect may continue even after discontinuation. Patients with decreased liver or kidney function may require dosage adjustments, so they should consult their physician. This medication may enhance the effect when taken with other antihypertensive drugs, so caution is required during co-administration. It is advisable to avoid taking it with grapefruit juice as it can increase serum concentration and pose a higher risk of side effects. During pregnancy, this medication should not be taken for the health of the fetus, and it is also considered safe not to take it while breastfeeding. There is no established safety or efficacy in children and adolescents under 18 years, so its use is not recommended. Overdose can lead to severe hypotension and cardiac issues, so it is important to adhere to the prescribed dosages and consult medical personnel immediately if any abnormal symptoms occur. This medication should be kept out of reach of children, and transferring it to another container should be avoided.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 162 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vasculitis
  • hyperreflexia
  • sensory loss
  • dysesthesia
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramping
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • sinus disorder
  • pharyngitis
  • myalgia
  • swelling
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory diminishment
  • decreased libido
  • memory impairment
  • migraine
  • irritability
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • sweating
  • angioedema
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • decreased vision
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylaxis syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the medication and ensure safe usage.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

Bottle packaging - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.